Suchergebnisse - "Patrikidou, Anna"

PubPharm (129)

1

Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel : The PACAP Study

enthalten in: European urology oncology | 2024

von Flippot, R. | Telli, T. | Velev, M. | +26

2

Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Helal, C. | Pobel, C. | Bayle, A. | +17

3

Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Menssouri, N. | Poiraudeau, L. | Helissey, C. | +33

CommentIn: Clin Cancer Res. 2023 Nov 1;29(21):4323-4325. - PMID 37646769

4

Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer

enthalten in: European urology oncology | 2023

von Bigot, L. | Sabio, J. | Poiraudeau, L. | +29

5

European Association of Urology Guidelines on Testicular Cancer : 2023 Update

enthalten in: European urology | 2023

von Patrikidou, A. | Cazzaniga, W. | Berney, D. | +16

6

Rucaparib or Physician's Choice in Metastatic Prostate Cancer

enthalten in: The New England journal of medicine | 2023

von Fizazi, K. | Piulats, J. | Reaume, M. | +126

CommentIn: Nat Rev Urol. 2023 Apr;20(4):199. - PMID 36928618

7

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma

enthalten in: Cancers | 2023

von Parent, P. | Auclin, E. | Patrikidou, A. | +15

8

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

enthalten in: Journal of translational medicine | 2023

von Nuzzo, P. | Pederzoli, F. | Saieva, C. | +16

9

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

enthalten in: Journal of translational medicine | 2023

von Nuzzo, P. | Pederzoli, F. | Saieva, C. | +15

10

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

enthalten in: Journal of translational medicine | 2023

von Nuzzo, P. | Pederzoli, F. | Saieva, C. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]